Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs

被引:100
|
作者
Pasquereau, Sebastien [1 ]
Kumar, Amit [1 ]
Herbein, Georges [1 ]
机构
[1] Univ Franche Comte, Dept Virol, Univ Bourgogne Franche Comte UBFC,CHRU Besancon, UPRES Pathogens & Inflammat EA4266,EPILAB,SFR FED, F-25030 Besancon, France
来源
VIRUSES-BASEL | 2017年 / 9卷 / 04期
关键词
TNF; TNF receptor; HIV-1; reservoirs; immune activation; anti-TNF therapy; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; CD4(+) T-CELLS; PRIMARY HUMAN MACROPHAGES; PERIPHERAL-BLOOD MONOCYTES; REACTIVATES LATENT HIV-1; FACTOR-ALPHA; SIGNAL-TRANSDUCTION; TERMINAL KINASE;
D O I
10.3390/v9040064
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several cellular functions such as apoptosis, cellular proliferation, inflammation, and immune regulation involve the tumor necrosis factor-alpha (TNF)/TNF receptor (TNFR) pathway. Human immunodeficiency virus 1 (HIV-1) interacts with the TNF/TNFR pathway. The activation of the TNF/TNFR pathway impacts HIV-1 replication, and the TNF/TNFR pathway is the target of HIV-1 proteins. A hallmark of HIV-1 infection is immune activation and inflammation with increased levels of TNF in the plasma and the tissues. Therefore, the control of the TNF/TNFR pathway by new therapeutic approaches could participate in the control of immune activation and impact both viral replication and viral persistence. In this review, we will describe the intricate interplay between HIV-1 proteins and TNF/TNFR signaling and how TNF/TNFR activation modulates HIV-1 replication and discuss new therapeutic approaches, especially anti-TNF therapy, that could control this pathway and ultimately favor the clearance of infected cells to cure HIV-infected patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Targeting TNF-Alpha in HIV-1 Infection
    Kumar, Amit
    Coquard, Laurie
    Herbein, Georges
    CURRENT DRUG TARGETS, 2016, 17 (01) : 15 - 22
  • [2] The challenge of viral reservoirs in HIV-1 infection
    Blankson, JN
    Persaud, D
    Siliciano, RF
    ANNUAL REVIEW OF MEDICINE, 2002, 53 : 557 - 593
  • [3] The implications of viral reservoirs on the elite control of HIV-1 infection
    Buckheit, Robert W., III
    Salgado, Maria
    Martins, Karen O.
    Blankson, Joel N.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (06) : 1009 - 1019
  • [4] The implications of viral reservoirs on the elite control of HIV-1 infection
    Robert W. Buckheit III
    Maria Salgado
    Karen O. Martins
    Joel N. Blankson
    Cellular and Molecular Life Sciences, 2013, 70 : 1009 - 1019
  • [5] Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis
    Montaner, LJ
    Perno, CF
    Crowe, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 68 (03) : 301 - 302
  • [6] HIV-1 INFECTION IN THE CNS - A ROLE FOR TNF-ALPHA
    WILT, SG
    GILBERT, D
    ZHOU, JM
    WESSELINGH, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S80 - S80
  • [7] Lipodystrophy in patients with HIV-1 infection:: effect of stopping protease inhibitors on TNF-α and TNF-receptor levels, and on metabolic parameters
    Maher, B
    Lloyd, J
    Wilkins, EGL
    Fraser, WD
    Back, D
    Park, BK
    Pirmohamed, M
    ANTIVIRAL THERAPY, 2004, 9 (06) : 879 - 887
  • [8] Sex differences in HIV-1 viral load and TNF-α plasmatic level?
    Savès, M
    Morlat, P
    Chêne, G
    Domon, B
    Peuchant, E
    AIDS, 1999, 13 (11) : 1414 - 1415
  • [9] Innate Immune Activation in Primary HIV-1 Infection
    Chang, J. Judy
    Altfeld, Marcus
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 : S297 - S301
  • [10] NK Cells and immune activation in HIV-1 infection
    Goodier, Martin R.
    RETROVIROLOGY, 2010, 7 : 5 - 5